首页> 外文期刊>World neurosurgery >Recurrence-free chronic subdural hematomas: A retrospective analysis of the instillation of tissue plasminogen activator in addition to twist drill or burr hole drainage in the treatment of chronic subdural hematomas
【24h】

Recurrence-free chronic subdural hematomas: A retrospective analysis of the instillation of tissue plasminogen activator in addition to twist drill or burr hole drainage in the treatment of chronic subdural hematomas

机译:无复发的慢性硬膜下血肿:回顾性分析组织纤维蛋白溶酶原激活剂除麻花钻或毛刺孔引流术外治疗慢性硬膜下血肿

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To evaluate whether increasing the volume drained from chronic subdural hematomas (SDHs) via either twist drill drainage (TDD) or burr hole drainage (BHD) followed by instillation of tissue plasminogen activator (tPA) is more efficacious than simple drainage alone. Methods: Patients admitted over the course of 42 months (2007-2010) to a single institution for treatment of chronic SDH were retrospectively evaluated. Results: There were 139 patients treated for chronic SDH; 54 patients were treated with BHD alone, 3 were treated with tPA after BHD, 85 were treated with TDD alone, and 12 were treated with tPA after TDD. Follow-up examinations were performed 1 month after treatment in 13 of 15 patients treated with tPA and 93 of 124 patients treated without tPA. Patients treated with tPA had a significantly lower rate of recurrence than patients treated without tPA (P = 0.041). Patients treated with BHD had a recurrence rate of 11.8%, whereas patients treated with BHD and tPA had 0% recurrence. Patients treated with TDD had a recurrence rate of 30%, whereas patients treated with TDD and tPA had 0% recurrence. Without tPA, BHD was found to be a significantly better treatment than TDD (P = 0.016). Mean drainage for TDD with tPA was 427.33 mL. There were no complications related to the administration of tPA. Conclusions: This study adds another therapeutic option for patients with chronic SDH requiring treatment. In this retrospective study, the addition of tPA increased the volume of hematoma drained and significantly reduced the incidence of recurrence requiring further intervention regardless of cranial access route. No complications occurred related directly or indirectly to the administration of tPA. Further study of this technique is warranted.
机译:目的:评估通过麻花钻引流术(TDD)或钻孔孔引流术(BHD)滴注组织纤维蛋白溶酶原激活剂(tPA)来增加从慢性硬膜下血肿(SDH)引流的体积是否比单纯单纯引流更有效。方法:回顾性评估在42个月(2007-2010年)入院治疗慢性SDH的患者。结果:139例接受慢性SDH治疗的患者。 54例患者单独接受BHD治疗,3例患者在BHD治疗后接受tPA治疗,85例仅接受TDD治疗,12例接受TDD治疗后接受tPA治疗。治疗后1个月,对15位接受tPA治疗的患者中的13位患者和124位未接受tPA治疗的患者中的93位进行了随访检查。用tPA治疗的患者的复发率明显低于未使用tPA治疗的患者(P = 0.041)。 BHD治疗的患者复发率为11.8%,而BHD和tPA治疗的患者复发率为0%。用TDD治疗的患者复发率为30%,而用TDD和tPA治疗的患者复发率为0%。没有tPA,发现BHD比TDD更好(P = 0.016)。含tPA的TDD的平均排出量为427.33 mL。没有与tPA给药相关的并发症。结论:本研究为需要治疗的慢性SDH患者增加了另一种治疗选择。在这项回顾性研究中,添加tPA可以增加引流的血肿量,并显着降低复发的发生率,而无论是否经过颅骨通路,都需要进一步干预。没有发生与tPA给药直接或间接相关的并发症。有必要对该技术进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号